Physician profile
Tammy Dann
NPI 1932361573
$431,447.49
in general payments reported to CMS, 2019-2025
49 companies · $72K in 2025
The $72K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,098 · 2020: $31K · 2021: $72K · 2022: $115K · 2023: $63K · 2024: $73K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $173K · Travel and Lodging: $17K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $173,081.25 |
| Travel and Lodging | $17,138.17 |
| Food and Beverage | $15,261.08 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $383,168.40 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Medtronic USA, INC. | $31,220.34 | 2019-2020 | |
| Abbott Laboratories | $5,006.79 | 2019-2025 | Proclaim, Eterna, Prodigy |
| Vertiflex, INC. | $2,037.23 | 2019 | |
| Abbvie INC. | $1,082.06 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Vertos Medical, INC. | $1,039.90 | 2020-2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $971.82 | 2019-2025 | Prialt |
| Nevro Corp. | $950.11 | 2019-2023 | Senza |
| Stimwave Technologies Incorporated | $893.46 | 2019-2022 | |
| Boston Scientific Corporation | $620.28 | 2019-2025 | General - Pain Management |
| Spr Therapeutics, INC | $599.65 | 2020-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $384.30 | 2019-2025 | Xtampza, Belbuca |
| Curonix LLC | $383.40 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $343.93 | 2019-2025 | |
| Pfizer INC. | $323.91 | 2019-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Dann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.